Iovance Biotherapeutics Inc (NASDAQ:IOVA)

20.12
Delayed Data
As of Oct 21
 +0.55 / +2.81%
Today’s Change
7.26
Today|||52-Week Range
26.59
+127.34%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization999.0K978.0K952.0K956.0K
 
 
 
 
 
 
Operating ExpensesGross Income-999.0K-978.0K-952.0K-956.0K
 
 
 
 
 
General Expenses26.9M52.7M91.9M127.3M
 
 
 
 
 
Research And Development15.5M28.0M71.6M99.8M
 
 
 
 
 
Total Operating Expenses27.9M53.6M92.9M128.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-27.9M-53.6M-92.9M-128.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-27.7M-52.9M-92.1M-123.6M
 
 
 
 
 
Preferred Dividend0.00-49.5M----
 
 
Net Income-27.7M-52.9M-92.1M-123.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS44.4M55.3M65.2M97.3M
 
 
 
 
 
Shares To Calculate EPS Diluted44.4M55.3M65.2M97.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.62-$1.85-$1.41-$1.27
 
 
 
 
 
EPS Diluted-$0.62-$1.85-$1.41-$1.27